Rankings
▼
Calendar
ORKA FY 2023 Earnings — Oruka Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ORKA
Oruka Therapeutics, Inc.
$1B
FY 2023 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$111,000
Operating Income
-$7M
Net Income
-$5M
EPS (Diluted)
$-4.44
Balance Sheet
Total Assets
$38M
Total Liabilities
$841,000
Stockholders' Equity
$37M
Cash & Equivalents
$37M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$111,000
-$114,000
+2.6%
Operating Income
-$7M
-$10M
+25.9%
Net Income
-$5M
-$10M
+46.2%
← Q4 2022
All Quarters
Q1 2023 →